The Synergistic Multi-Pathway Regeneration Peptide Also known as: Glow Protocol, Aesthetic Support Complex, BPC-157/TB-500/GHK-Cu Blend
Why Researchers Choose GLOW Blend
Unlike single-peptide approaches, GLOW Peptide Blend combines three mechanistically distinct peptides that work across multiple biological repair pathways simultaneously—delivering synergistic effects that exceed what any individual peptide achieves alone. This multi-pathway approach makes it uniquely valuable for researchers studying comprehensive tissue regeneration where wound healing, collagen synthesis, and cellular migration need to occur together.
What It Is
GLOW Peptide Blend is a precisely formulated combination of BPC-157, TB-500 (Thymosin Beta-4), and GHK-Cu—three peptides with complementary regenerative mechanisms. Think of it like assembling a repair team where each member has specialized skills, but together they can tackle complex reconstruction projects that would overwhelm any single worker.
Researchers became interested because early studies showed that combining these peptides produced accelerated healing timelines and improved tissue quality outcomes compared to individual peptide applications.
How It Works (What Makes It Interesting)
Studies suggest GLOW Peptide Blend influences tissue repair through multiple synergistic mechanisms:
• Multi-pathway angiogenesis – BPC-157 activates VEGFR2 signaling while TB-500 upregulates VEGF expression, creating robust new blood vessel formation from two different angles
• Enhanced cellular migration – TB-500’s actin-sequestering properties facilitate cell movement while BPC-157’s FAK-paxillin pathway activation guides repair cells to injury sites
• Comprehensive collagen regulation – GHK-Cu stimulates metalloproteinase enzymes for protein breakdown and anti-protease production for protein preservation, while TB-500 increases collagen deposition rates
• Coordinated inflammation control – All three peptides reduce inflammatory cytokines through distinct pathways (nitric oxide modulation, copper-mediated signaling, and actin regulation)
• Growth factor amplification – BPC-157 upregulates growth hormone receptors making cells more responsive to natural growth signals enhanced by the other peptides
Common Research Applications
Wound Healing Models: Surgical incisions, diabetic ulcers, chronic wounds, post-surgical recovery, scar formation studies
Musculoskeletal Research: Tendon tears, ligament injuries, muscle damage, connective tissue repair, post-exercise recovery models
Dermatological Studies: Skin aging models, collagen synthesis research, elastin production, wrinkle formation, skin barrier function
Angiogenesis Research: Blood vessel formation, vascular repair, ischemic tissue models, microcirculation studies
Anti-inflammatory Applications: Cytokine modulation studies, inflammatory bowel models, tissue inflammation, immune response research
Cosmetic Science: Anti-aging mechanisms, skin rejuvenation pathways, hair follicle stimulation, aesthetic regeneration research
What You’re Getting
Every batch of our GLOW Peptide Blend meets rigorous research standards:
Exceeds 99% Purity – Verified by HPLC analysis Certificate of Analysis (COA) – Included with every order, showing purity and identity confirmation Endotoxin-Free – Tested to ensure <1 EU/mg for cell culture applications Manufactured in USA – GMP-certified facilities with full traceability Sterile & Lyophilized – Stable for long-term storage, easy reconstitution Fast Shipping – Most orders ship same day. We offer flat rate shipping and 2-3 day delivery in the USA
Click the “Add To Cart” button to grab your GLOW Blend today!
Research Use Only
Research Use Only This product is intended strictly for laboratory research purposes. Not for human consumption, clinical use, veterinary applications, or any diagnostic or therapeutic purposes.
GLOW Peptide Blend Research & Scientific Overview
Jump to: Structure | Mechanism | Studies | Pharmacokinetics | Protocols | Limitations | Lead Researcher | References
GLOW Blend Molecular Structure & Chemical Properties
GLOW Blend represents a synergistic combination of three extensively studied regenerative peptides – BPC-157, TB-500, and GHK-Cu – developed to provide comprehensive tissue repair and regenerative effects in preclinical research models. This peptide formulation was created to investigate the potential additive or synergistic benefits of combining three distinct mechanisms of action into a single research tool. The blend leverages the stability characteristics of each component peptide, with BPC-157’s resistance to gastric acid degradation, TB-500’s actin-binding properties, and GHK-Cu’s copper-mediated enzymatic activities working in concert to promote tissue healing across multiple pathways.
Chemical Composition GLOW Blend Component Peptides Molecular Structure (BPC-157 component shown)
Representative component structure (BPC-157) – blend contains three distinct peptides (Source: PubChem)
Technical Specifications
Property Value Primary Components BPC-157, TB-500, GHK-Cu BPC-157 CAS Number 137525-51-0 TB-500 CAS Number 885340-08-9 GHK-Cu CAS Number 89030-95-5 Combined Molecular Weight ~6,672 g/mol (sum of components) BPC-157 Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB-500 Sequence Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser GHK-Cu Structure Glycyl-L-histidyl-L-lysine copper complex Stability Room temperature stable (lyophilized); BPC-157 gastric acid resistant Solubility Water soluble; reconstitutes in bacteriostatic water or saline Storage Lyophilized: -20 degrees C; Reconstituted: 2-8 degrees C
The blend combines three distinct peptide classes: a gastric-derived pentadecapeptide (BPC-157), an actin-sequestering peptide (TB-500), and a copper-binding tripeptide (GHK-Cu), creating a multifaceted research tool for tissue regeneration studies.
GLOW Blend Mechanism of Action
GLOW Blend exerts its biological effects through three complementary but distinct molecular pathways that work synergistically to promote tissue repair, angiogenesis, and cellular regeneration. Rather than targeting a single receptor or pathway, this peptide combination activates multiple interconnected signaling networks that collectively enhance healing responses beyond what individual components might achieve alone.
Primary Cellular Pathways
FAK/Paxillin Signaling – Cell Migration Enhancement
BPC-157 significantly increases phosphorylation of focal adhesion kinase (FAK) and paxillin proteins in fibroblast cells, promoting enhanced cell adhesion and migration1. This pathway activation enables:
Accelerated migration of repair cells to injury sites Improved cell survival under oxidative stress conditions Enhanced F-actin formation essential for cellular movement Increased fibroblast outgrowth and spreading capacity
Research using FITC-phalloidin staining demonstrated that BPC-157 potently stimulates F-actin formation, providing the structural foundation for improved cellular mechanics throughout the healing process.
Actin Sequestration and Cytoskeletal Remodeling
TB-500 functions as the primary actin-sequestering molecule in the blend, binding globular actin (G-actin) and regulating actin polymerization2. This mechanism involves:
Control of actin filament assembly and disassembly Enhanced cellular migration through cytoskeletal reorganization Improved cell morphological changes during repair processes Regulation of cellular mechanical properties
The peptide’s actin-binding domain (LKKTET sequence) allows precise modulation of cytoskeletal dynamics, enabling cells to migrate more effectively to sites requiring repair.
Copper-Mediated Matrix Remodeling
GHK-Cu promotes extracellular matrix synthesis and remodeling through copper-dependent enzymatic activation3. Key mechanisms include:
Stimulation of collagen and elastin synthesis in fibroblasts Activation of lysyl oxidase for collagen cross-linking Enhanced production of glycosaminoglycans and decorin Modulation of metalloproteinase activity for controlled matrix breakdown
The copper ion serves as an essential cofactor for enzymes involved in collagen synthesis and provides antioxidant protection through superoxide dismutase activation.
Angiogenic Pathway Activation
Multiple components contribute to blood vessel formation through distinct but complementary mechanisms4:
BPC-157 upregulates VEGFR2 expression and enhances endothelial cell proliferation TB-500 promotes endothelial cell migration and tube formation GHK-Cu stimulates angiogenic growth factor expression and vessel maturation Combined effects result in improved tissue vascularization and nutrient delivery
Anti-Inflammatory Pathway Modulation
The blend provides comprehensive inflammation control through multiple targets5:
BPC-157 modulates nitric oxide synthesis and reduces pro-inflammatory cytokines TB-500 influences inflammatory mediator expression through cytoskeletal mechanisms GHK-Cu reduces oxidative stress and modulates immune cell function Coordinated effects help resolve inflammation while promoting healing
Synergistic Advantage: GLOW Blend’s multi-pathway approach enables simultaneous activation of cellular migration, matrix synthesis, angiogenesis, and inflammation control. This comprehensive mechanism distinguishes it from single-peptide approaches and may explain enhanced healing responses observed in preliminary research models.
GLOW Peptide Blend Research Applications & Key Findings
Musculoskeletal Tissue Research
Tendon and Ligament Healing Studies
Research investigating the individual components has demonstrated significant effects on connective tissue repair. BPC-157 studies in rat models showed accelerated healing in Achilles tendon transection models with improved biomechanical properties6. Key findings include:
Enhanced load-to-failure measurements in healing tendons compared to controls Improved collagen organization and fiber alignment at injury sites Accelerated tendon-to-bone healing in ligament injury models Dose-dependent effects with optimal responses observed at 10 mcg/kg in rodent studies
TB-500 research demonstrated enhanced cellular migration and actin polymerization in tendon fibroblasts, while GHK-Cu studies showed increased collagen synthesis and improved tissue remodeling7. Combined research suggests potential synergistic effects for comprehensive connective tissue repair.
Muscle Injury and Recovery Research
Studies on component peptides in muscle injury models revealed complementary healing mechanisms8:
BPC-157 showed faster restoration of muscle architecture in crush injury models TB-500 enhanced satellite cell activation and myofiber regeneration GHK-Cu improved collagen content and reduced fibrosis formation Combined mechanisms suggest enhanced functional recovery potential
Bone and Cartilage Research
Investigations in fracture and cartilage models demonstrated effects on bone repair processes, including improved callus formation and mineralization in animal studies9.
Dermatological and Wound Healing Research
Skin Regeneration Studies
Research on individual components has shown significant effects on dermal wound healing and skin regeneration10. Findings include:
Accelerated wound closure rates in multiple animal models Enhanced re-epithelialization and granulation tissue formation Improved collagen deposition and organization in healing wounds Reduced scar formation and improved cosmetic outcomes
GHK-Cu specifically demonstrated increases in skin thickness, elasticity, and firmness in controlled studies, while BPC-157 showed protective effects against various skin damage models.
Hair Follicle and Regenerative Research
Preliminary research suggests potential effects on hair follicle development and growth, with thymosin beta-4 research showing accelerated hair growth in deficient animal models11.
Gastrointestinal Research Applications
Mucosal Protection and Healing
BPC-157 research has extensively documented gastroprotective and intestinal healing effects12. Studies showed:
Healing acceleration in NSAID-induced gastric ulcers (rat models) Protection against ethanol and stress-induced mucosal damage Effective healing of inflammatory bowel disease lesions in experimental colitis Fistula healing demonstrated in various gastrointestinal models
Cardiovascular Research
Vascular Injury and Protection Studies
Research on component peptides examined effects in various cardiovascular scenarios13:
Improved healing in vascular anastomosis models Protection against arrhythmias in toxicity models Enhanced angiogenesis and collateral circulation development Potential cardioprotective effects in ischemia-reperfusion models
Critical Research Gap: While individual components show promising effects across multiple tissue types, comprehensive studies specifically examining GLOW Blend as a combined formulation remain limited. Most data comes from individual peptide research, and human clinical trials for the combination are completely absent from peer-reviewed literature.
GLOW Peptide Blend Pharmacokinetics & Metabolism
Absorption & Distribution
GLOW Blend pharmacokinetics reflect the combined properties of its three component peptides, each with distinct absorption and distribution characteristics14. Following administration in animal models:
BPC-157 demonstrates rapid systemic distribution within 15-30 minutes of administration TB-500 shows tissue-specific accumulation with preferential uptake in injured areas GHK-Cu exhibits copper-mediated transport and tissue binding characteristics Combined formulation provides both immediate and sustained bioactivity
Distribution studies suggest that while each peptide follows distinct pathways, injury sites tend to concentrate all three components, potentially enhancing local therapeutic effects through multiple mechanisms.
Metabolism & Elimination
The metabolic fate of GLOW Peptide Blend involves parallel processing of three distinct peptides15:
BPC-157 plasma half-life under 30 minutes but biological effects persist for hours TB-500 undergoes C-terminal degradation with serial cleavage patterns GHK-Cu metabolism involves copper release and peptide fragment formation Complex interaction between components may influence individual clearance rates
A significant pharmacokinetic paradox exists: despite rapid plasma clearance of individual components, biological effects often persist well beyond plasma elimination, suggesting tissue retention, active metabolite formation, or persistent signaling cascade activation.
Excretion Pathways
Limited data on combined excretion indicates16:
Primarily renal elimination of peptide fragments Hepatic metabolism contributes to overall clearance Copper recycling through normal physiological pathways No evidence of accumulation in chronic dosing studies (animal models)
The relationship between rapid plasma clearance and prolonged biological effects represents a key area requiring further mechanistic investigation across all three components.
GLOW Blend Research Protocols & Administration
Dosing in Published Research
Research investigations of individual components have employed various dosing strategies that inform potential combination approaches:
BPC-157 studies: 10 mcg/kg most common in rat models (range: 1-1000 mcg/kg) TB-500 studies: 1-10 mg/kg typical range in rodent research GHK-Cu studies: 0.01-100 nanomolar concentrations in cell culture; 1-10 mg/kg in animal studies Combined formulations: Ratios vary widely across research suppliers (5-50mg GHK-Cu, 5-10mg BPC-157, 5-10mg TB-500)
Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, receptor density, pharmacokinetics, and peptide degradation rates. Species-specific factors profoundly influence both efficacy and safety profiles across all three peptide components.
Administration Routes in Research
Multiple delivery methods have been investigated for component peptides:
Subcutaneous injection – Most common route for combined formulations in research Intraperitoneal injection – Used in systemic studies, University of Zagreb School of Medicine, Zagreb, Croatia
Professor Predrag Sikiric has been the primary investigator for BPC-157 research since the 1990s, establishing the foundational research base for one of the key components in GLOW Peptide Blend. His laboratory has published the majority of preclinical studies examining BPC-157’s effects across multiple organ systems, contributing significantly to understanding peptide-based tissue repair mechanisms.
Professor Sikiric’s research contributions include:
Initial isolation and characterization of BPC-157 from human gastric secretions Extensive investigations of gastroprotective and tissue healing mechanisms Pioneering studies on musculoskeletal tissue repair including tendon and muscle healing Research on cardiovascular protective effects and vascular injury healing Over 400 published papers examining BPC-157’s pleiotropic effects across organ systems
His work has established BPC-157 as one of the most comprehensively studied components in peptide-based regenerative research, though human clinical validation remains absent. The foundational research from his laboratory has contributed to the scientific rationale for combination peptide formulations like GLOW Peptide Blend.
Disclaimer: This spotlight is provided for educational purposes to acknowledge scientific contributions to peptide research relevant to GLOW Peptide Blend components. Cenexa Labs has no affiliation with Professor Sikiric or the University of Zagreb, and this information does not constitute an endorsement of any products or services.
References
Chang, C.H., Tsai, W.C., Lin, M.S., Hsu, Y.H., & Pang, J.H. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 110(3), 774-780. PubMed Philp, D., Badamchian, M., Scheremeta, B., Nguyen, M., Goldstein, A.L., & Kleinman, H.K. (2003). Thymosin beta4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair and Regeneration, 11(1), 19-24. PubMed Pickart, L., & Margolina, A. (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences, 19(7), 1987. PubMed Seiwerth, S., Rucman, R., Turkovic, B., Sever, M., Klicek, R., Radic, B., Drmic, D., Stupnisek, M., Misic, M., Vuletic, L.B., & Sikiric, P. (2018). BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Current Pharmaceutical Design, 24(18), 1972-1989. PubMed Shah, R., Reyes-Gordillo, K., Cheng, Y., Varatharajalu, R., Ibrahim, J., & Lakshman, M.R. (2018). Thymosin beta4 prevents oxidative stress, inflammation, and fibrosis in ethanol- and LPS-induced liver injury in mice. Oxidative Medicine and Cellular Longevity, 2018, 9630175. PubMed Krivic, A., Anic, T., Seiwerth, S., Huljev, D., & Sikiric, P. (2006). Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation. Journal of Orthopaedic Research, 24(5), 982-989. PubMed Staresinic, M., Sebecic, B., Patrlj, L., Jadrijevic, S., Suknaic, S., Perovic, D., Aralica, G., Zarkovic, N., Borovic, S., Srdjak, M., Hajdar, S., Kopljar, M., Batelja, L., Boban-Blagaic, A., Turcic, I., Amic, F., Ruenzi, E., Rucman, R., Seiwerth, S., & Sikiric, P. (2006). Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. Journal of Orthopaedic Research, 24(5), 1109-1117. PubMed Goldstein, A.L., Hannappel, E., Sosne, G., & Kleinman, H.K. (2012). Thymosin beta4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opinion on Biological Therapy, 12(1), 37-51. PubMed Tkalcevic, V.I., Cuzic, S., Brajsa, K., Mildner, B., Bokulic, A., Situm, K., Perovic, D., Glojnaric, I., & Parnham, M.J. (2007). Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. European Journal of Pharmacology, 570(1-3), 212-221. PubMed Maquart, F.X., Pickart, L., Laurent, M., Gillery, P., Monboisse, J.C., & Borel, J.P. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters, 238(2), 343-346. PubMed Philp, D., Badamchian, M., Scheremeta, B., Nguyen, M., Goldstein, A.L., & Kleinman, H.K. (2004). Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mechanisms of Ageing and Development, 125(2), 113-115. PubMed Sikiric, P., Seiwerth, S., Rucman, R., Turkovic, B., Rokotov, D.S., Brcic, L., Sever, M., Klicek, R., Radic, B., Drmic, D., Ilic, S., & Kolenc, D. (2013). Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract. Current Pharmaceutical Design, 19(1), 126-132. PubMed Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., Gojkovic, S., Krezic, I., Vidovic, T., Bilic, Z., Sjekavica, I., Djuzel, A.R., Knezevic, M., Sever, A.Z., Lojo, N., Kokot, A., Sever, M., Drmic, D., Seiwerth, S., & Sikiric, P. (2017). Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World Journal of Gastroenterology, 23(48), 8465-8488. PubMed Sikiric, P., Separovic, J., Anic, T., Buljat, G., Mikus, D., Seiwerth, S., Grabarevic, Z., Stancic-Rokotov, D., Pigac, B., Hanzevacki, M., Marovic, A., Rucman, R., Petek, M., Ziger, T., Sebecic, B., Zoricic, I., Turkovic, B., Aralica, G., Perovic, D., Duplancic, B., Lovric-Bencic, M., & Rotkvic, I. (2001). The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure. European Journal of Pharmacology, 332(1), 23-33. PubMed Ho, E.N., Kwok, W.H., Lau, M.Y., Wong, A.S., Wan, T.S., Lam, K.K., Schiff, P.J., Morishima, M., & Wong, C.H. (2012). Doping control analysis of TB-500, a synthetic version of an active region of thymosin beta4, in equine urine and plasma by liquid chromatography-mass spectrometry. Journal of Chromatography A, 1265, 57-69. PubMed Pickart, L., Vasquez-Soltero, J.M., & Margolina, A. (2017). GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International, 2017, 5831582. PubMed Sikiric, P., Hahm, K.B., Blagaic, A.B., Tvrdeic, A., Pavlov, K.H., Petrovic, A., Kokot, A., Gojkovic, S., Krezic, I., Drmic, D., Rucman, R., & Seiwerth, S. (2020). Stable gastric pentadecapeptide BPC 157, Robert’s stomach cytoprotection/adaptive cytoprotection/organoprotection, and Selye’s stress coping response: Progress, achievements, and the future. Gut and Liver, 14(2), 153-167. PubMed Malinda, K.M., Sidhu, G.S., Mani, H., Banaudha, K., Maheshwari, R.K., Goldstein, A.L., & Kleinman, H.K. (1999). Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology, 113(3), 364-368. PubMed
All references open in new window. These citations are provided for educational and research purposes only. This information is not intended to diagnose, treat, cure, or prevent any disease. GLOW Peptide Blend is intended for laboratory research use only.
The Cenexa Labs Gold Standard
Most peptide sites simply resell vials from overseas labs with little oversight or testing (Much of it is either fake or laced with contaminants). At Cenexa Labs, we manufacture our own peptides under strict USA-based standards...right here IN THE USA. From synthesis to lyophilization to final vial, every step is handled under our direct control — so you never have to question what you’re getting.
We might not be the cheapest, but you can count on our peptides being 100% legit and free from contaminants, heavy metals and toxins.
Why Researchers Choose Cenexa Labs
End-to-End Chain of Custody: Every batch is logged, tested, and traceable — no middlemen, no relabeling, no guesswork. Lot-Linked COAs: Each vial’s lot number ties directly to third-party HPLC/MS results. No recycled or generic COAs. We’re the Manufacturer: Because we produce in-house, we control purity, potency, and compliance — instead of reselling from anonymous overseas labs. Verified Purity, Every Time: 99%+ purity confirmed on every batch by independent labs, not just claimed on a label. GMP-Aligned, USA Based: Manufactured domestically in controlled GMP, ISO 9001-audited facilities. Fast, Reliable Fulfillment: Orders placed by 2pm CST ship the same business day. Free USPS Priority on orders $300+. $9.95 Flat rate shipping on all other orders with 2-3 day delivery. Backed by Trust: Over 18,000 researchers nationwide rely on Cenexa Labs for consistent, verifiable peptides.
Room Temperature (Unmixed): Lyophilized (powder) peptides are stable for 3–4 months at room temperature if kept sealed and away from direct light. Freezer (Unmixed): For long-term storage, place vials in a freezer. Depending on temperature, peptides can remain stable for 1–3 years. After Reconstitution: Once mixed with bacteriostatic water, peptides must be stored in the refrigerator and remain stable for up to 30 days.
All Cenexa peptides are manufactured 100% end-to-end here in the USA using the Lyophilization (Freeze Drying) process. This ensures maximum stability and quality.
Best Practice: Only reconstitute your peptides when you’re ready to begin using them. Until then, keep vials in their lyophilized powder form, stored in the freezer and away from light.
Fast Processing: We strive to ship same-day. During high-volume times it may take 2–3 days for your package to enter the mailstream. (You’ll see a notice at checkout and can upgrade if you need guaranteed same-day shipping.)
Flat Rate Shipping: $9.95 on all orders (USPS Priority Mail 2–3 days). Free Shipping: Orders over $300 ship free. Expedited Options: Faster methods available at checkout.
Important: Orders paid by eCheck won’t ship until payment clears our bank (usually 2–3 business days after it leaves your account).
All products are carefully packaged for safe arrival.
Need help with your order or delivery?